Google News – Clinical Trials External News
Life Sciences & Pharma Articles
Google News – Oncology External News
Medicus Pharma Advances Transformation Into A Precision Oncology-Led Biotechnology Company - tradingview.com
Google News – Oncology External News
Medicus Pharma shifts focus to precision oncology with CD228V By Investing.com - Investing.com UK
Google News – Oncology External News
Medicus Pharma Ltd. Repositions as Precision Oncology-Led Biotech, Prioritizes CD228V, SkinJect and Teverelix Programs - Quiver Quantitative
Google News – Biopharma External News
A 10% slice of Zenas BioPharma (NASDAQ: ZBIO) sits with one investment group - Stock Titan
Google News – Oncology External News
Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company - Yahoo Finance
Google News – Clinical Trials External News
Oncologists say newly approved pancreatic cancer drug is a breakthrough for treatment - healthcare-brew.com
Google News – Biopharma External News
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event - The Manila Times
Google News – Pharmaceuticals External News
X4 Pharmaceuticals: FDA OKs Reduced Sample Size for 4WARD Phase 3, Enrollment to Finish by Year-End 2026 - TradingView
Google News – FDA (biotech/pharma) External News
FDA backs smaller late-stage test of X4 (NASDAQ: XFOR) neutropenia drug, with pivotal data not due until 2028 - Stock Titan
Industry News External News
Sun Pharma gets ratings boost from Moody's, S&P over ₹11.75-billion Organon & Co acquisition bid - BusinessLine
Google News – Pharmaceuticals External News
Atea CEO to speak at a New York healthcare conference Sept. 15 - Stock Titan
Google News – Biopharma External News
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event - Yahoo! Finance Canada
Google News – Biopharma External News
VION Biosciences Expands Integrated Platform Across Biopharma Services and Diagnostic Workflow Capabilities - Business Wire
Google News – Pharmaceuticals External News